Major decline of hepatitis C virus incidence rate over two decades in a cohort of drug users View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2007-03-03

AUTHORS

Charlotte H. S. B. van den Berg, Colette Smit, Margreet Bakker, Ronald B. Geskus, Ben Berkhout, Suzanne Jurriaans, Roel A. Coutinho, Katja C. Wolthers, Maria Prins

ABSTRACT

Injecting drug users (DU) are at high risk for hepatitis C virus (HCV) and HIV infections. To examine the prevalence and incidence of these infections over a 20-year period (1985–005), the authors evaluated 1276 DU from the Amsterdam Cohort Studies who had been tested prospectively for HIV infection and retrospectively for HCV infection. To compare HCV and HIV incidences, a smooth trend was assumed for both curves over calendar time. Risk factors for HCV seroconversion were determined using Poisson regression. Among ever-injecting DU, the prevalence of HCV antibodies was 84.5% at study entry, and 30.9% were co-infected with HIV. Their yearly HCV incidence dropped from 27.5/100 person years (PY) in the 1980s to 2/100 PY in recent years. In multivariate analyses, ever-injecting DU who currently injected and borrowed needles were at increased risk of HCV seroconversion (incidence rate ratio 29.9, 95% CI 12.6, 70.9) compared to ever-injecting DU who did not currently inject. The risk of HCV seroconversion decreased over calendar time. The HCV incidence in ever-injecting DU was on average 4.4 times the HIV incidence, a pattern seen over the entire study period. The simultaneous decline of both HCV and HIV incidence probably results from reduced risk behavior at the population level. More... »

PAGES

183-193

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s10654-006-9089-7

DOI

http://dx.doi.org/10.1007/s10654-006-9089-7

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1034474780

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/17334821


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1108", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical Microbiology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Public Health and Health Services", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "HIV Infections", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hepatitis C", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Incidence", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Needle Sharing", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Needle-Exchange Programs", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Netherlands", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Serologic Tests", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Substance Abuse, Intravenous", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, Amsterdam, The Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.5650.6", 
          "name": [
            "Department of Human Retrovirology, Academic Medical Center, Amsterdam, The Netherlands", 
            "Department of Research, Cluster, Infectious Diseases, Health Service of Amsterdam, Nieuwe Achtergracht 100, 1018 WT, Amsterdam, The Netherlands", 
            "Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, Amsterdam, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "van den Berg", 
        "givenName": "Charlotte H. S. B.", 
        "id": "sg:person.013427673122.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013427673122.44"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, Amsterdam, The Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.5650.6", 
          "name": [
            "Department of Research, Cluster, Infectious Diseases, Health Service of Amsterdam, Nieuwe Achtergracht 100, 1018 WT, Amsterdam, The Netherlands", 
            "Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, Amsterdam, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Smit", 
        "givenName": "Colette", 
        "id": "sg:person.01276615013.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01276615013.07"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, Amsterdam, The Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.5650.6", 
          "name": [
            "Department of Human Retrovirology, Academic Medical Center, Amsterdam, The Netherlands", 
            "Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, Amsterdam, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bakker", 
        "givenName": "Margreet", 
        "id": "sg:person.0741421421.32", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0741421421.32"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Clinical Epidemiology and Biostatistics, Academic Medical Center, Amsterdam, The Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.5650.6", 
          "name": [
            "Department of Research, Cluster, Infectious Diseases, Health Service of Amsterdam, Nieuwe Achtergracht 100, 1018 WT, Amsterdam, The Netherlands", 
            "Department of Clinical Epidemiology and Biostatistics, Academic Medical Center, Amsterdam, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Geskus", 
        "givenName": "Ronald B.", 
        "id": "sg:person.01205235647.85", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01205235647.85"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, Amsterdam, The Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.5650.6", 
          "name": [
            "Department of Human Retrovirology, Academic Medical Center, Amsterdam, The Netherlands", 
            "Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, Amsterdam, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Berkhout", 
        "givenName": "Ben", 
        "id": "sg:person.01233471631.26", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01233471631.26"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, Amsterdam, The Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.5650.6", 
          "name": [
            "Department of Human Retrovirology, Academic Medical Center, Amsterdam, The Netherlands", 
            "Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, Amsterdam, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Jurriaans", 
        "givenName": "Suzanne", 
        "id": "sg:person.01257225511.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01257225511.14"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, Amsterdam, The Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.5650.6", 
          "name": [
            "Department of Human Retrovirology, Academic Medical Center, Amsterdam, The Netherlands", 
            "Center for Infectious Disease Control, National Institute of Public Health and the Environment, Bilthoven, The Netherlands", 
            "Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, Amsterdam, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Coutinho", 
        "givenName": "Roel A.", 
        "id": "sg:person.0636370562.38", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0636370562.38"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, Amsterdam, The Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.5650.6", 
          "name": [
            "Department of Human Retrovirology, Academic Medical Center, Amsterdam, The Netherlands", 
            "Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, Amsterdam, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wolthers", 
        "givenName": "Katja C.", 
        "id": "sg:person.01322117344.51", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01322117344.51"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, Amsterdam, The Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.5650.6", 
          "name": [
            "Department of Research, Cluster, Infectious Diseases, Health Service of Amsterdam, Nieuwe Achtergracht 100, 1018 WT, Amsterdam, The Netherlands", 
            "Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, Amsterdam, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Prins", 
        "givenName": "Maria", 
        "id": "sg:person.015770000052.12", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015770000052.12"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1023/a:1014560431726", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020276587", 
          "https://doi.org/10.1023/a:1014560431726"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00146260", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010552924", 
          "https://doi.org/10.1007/bf00146260"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1093/jurban/jth084", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051686894", 
          "https://doi.org/10.1093/jurban/jth084"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2007-03-03", 
    "datePublishedReg": "2007-03-03", 
    "description": "Injecting drug users (DU) are at high risk for hepatitis C virus (HCV) and HIV infections. To examine the prevalence and incidence of these infections over a 20-year period (1985\u2013005), the authors evaluated 1276 DU from the Amsterdam Cohort Studies who had been tested prospectively for HIV infection and retrospectively for HCV infection. To compare HCV and HIV incidences, a smooth trend was assumed for both curves over calendar time. Risk factors for HCV seroconversion were determined using Poisson regression. Among ever-injecting DU, the prevalence of HCV antibodies was 84.5% at study entry, and 30.9% were co-infected with HIV. Their yearly HCV incidence dropped from 27.5/100 person years (PY) in the 1980s to 2/100 PY in recent years. In multivariate analyses, ever-injecting DU who currently injected and borrowed needles were at increased risk of HCV seroconversion (incidence rate ratio 29.9, 95% CI 12.6, 70.9) compared to ever-injecting DU who did not currently inject. The risk of HCV seroconversion decreased over calendar time. The HCV incidence in ever-injecting DU was on average 4.4 times the HIV incidence, a pattern seen over the entire study period. The simultaneous decline of both HCV and HIV incidence probably results from reduced risk behavior at the population level.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s10654-006-9089-7", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1095636", 
        "issn": [
          "0393-2990", 
          "1573-7284"
        ], 
        "name": "European Journal of Epidemiology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "22"
      }
    ], 
    "keywords": [
      "hepatitis C virus", 
      "HCV seroconversion", 
      "HIV incidence", 
      "drug users", 
      "HCV incidence", 
      "HIV infection", 
      "person years", 
      "hepatitis C virus (HCV) incidence rates", 
      "Amsterdam Cohort Studies", 
      "calendar time", 
      "HCV infection", 
      "HCV antibodies", 
      "cohort study", 
      "study entry", 
      "C virus", 
      "risk factors", 
      "incidence rate", 
      "high risk", 
      "Poisson regression", 
      "multivariate analysis", 
      "risk behaviors", 
      "entire study period", 
      "seroconversion", 
      "incidence", 
      "infection", 
      "study period", 
      "prevalence", 
      "risk", 
      "population level", 
      "reduced risk behavior", 
      "HIV", 
      "cohort", 
      "years", 
      "simultaneous decline", 
      "antibodies", 
      "virus", 
      "period", 
      "decline", 
      "regression", 
      "needle", 
      "time", 
      "factors", 
      "levels", 
      "major decline", 
      "study", 
      "rate", 
      "entry", 
      "recent years", 
      "patterns", 
      "curves", 
      "analysis", 
      "decades", 
      "authors", 
      "trends", 
      "users", 
      "behavior", 
      "smooth trend"
    ], 
    "name": "Major decline of hepatitis C virus incidence rate over two decades in a cohort of drug users", 
    "pagination": "183-193", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1034474780"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s10654-006-9089-7"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "17334821"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s10654-006-9089-7", 
      "https://app.dimensions.ai/details/publication/pub.1034474780"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-10-01T06:34", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_434.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s10654-006-9089-7"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s10654-006-9089-7'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s10654-006-9089-7'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s10654-006-9089-7'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s10654-006-9089-7'


 

This table displays all metadata directly associated to this object as RDF triples.

251 TRIPLES      21 PREDICATES      100 URIs      87 LITERALS      20 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s10654-006-9089-7 schema:about N06c6419b5eba4f88a5582b662cbba791
2 N4002edc04037450db4727e9fae7c77e1
3 N4c097eef145c425cb5e31bf255daf4fa
4 N4dba47bf563f4329948047d410618383
5 N59023a8af5554bb2a625e08855da6f19
6 N5fdaf251c4554cacb6445f5d0153bc70
7 N68083fd4f6104afcb79de01af1703294
8 N695ec59fb6d144da9489039d3f2a4b24
9 Na9df5627dbe6440cbc5b9c087b3fdb05
10 Nabaa2005ff734ab785f75dd1b086ade7
11 Nafe79aa7288e4d90b932b81f3fa698b8
12 Ncf1ab4e2b70144729ea4217e3c319aca
13 Nf59fa8ada22d4bf6a1095634d08e6fc0
14 anzsrc-for:11
15 anzsrc-for:1103
16 anzsrc-for:1108
17 anzsrc-for:1117
18 schema:author Nd40c3f22b89544ada48fa39ca2e5f5c2
19 schema:citation sg:pub.10.1007/bf00146260
20 sg:pub.10.1023/a:1014560431726
21 sg:pub.10.1093/jurban/jth084
22 schema:datePublished 2007-03-03
23 schema:datePublishedReg 2007-03-03
24 schema:description Injecting drug users (DU) are at high risk for hepatitis C virus (HCV) and HIV infections. To examine the prevalence and incidence of these infections over a 20-year period (1985–005), the authors evaluated 1276 DU from the Amsterdam Cohort Studies who had been tested prospectively for HIV infection and retrospectively for HCV infection. To compare HCV and HIV incidences, a smooth trend was assumed for both curves over calendar time. Risk factors for HCV seroconversion were determined using Poisson regression. Among ever-injecting DU, the prevalence of HCV antibodies was 84.5% at study entry, and 30.9% were co-infected with HIV. Their yearly HCV incidence dropped from 27.5/100 person years (PY) in the 1980s to 2/100 PY in recent years. In multivariate analyses, ever-injecting DU who currently injected and borrowed needles were at increased risk of HCV seroconversion (incidence rate ratio 29.9, 95% CI 12.6, 70.9) compared to ever-injecting DU who did not currently inject. The risk of HCV seroconversion decreased over calendar time. The HCV incidence in ever-injecting DU was on average 4.4 times the HIV incidence, a pattern seen over the entire study period. The simultaneous decline of both HCV and HIV incidence probably results from reduced risk behavior at the population level.
25 schema:genre article
26 schema:isAccessibleForFree true
27 schema:isPartOf N01e3200ae30e43bb93b0ae5a67f30017
28 Nbf84998dc06a46d193bcbe2d407070b5
29 sg:journal.1095636
30 schema:keywords Amsterdam Cohort Studies
31 C virus
32 HCV antibodies
33 HCV incidence
34 HCV infection
35 HCV seroconversion
36 HIV
37 HIV incidence
38 HIV infection
39 Poisson regression
40 analysis
41 antibodies
42 authors
43 behavior
44 calendar time
45 cohort
46 cohort study
47 curves
48 decades
49 decline
50 drug users
51 entire study period
52 entry
53 factors
54 hepatitis C virus
55 hepatitis C virus (HCV) incidence rates
56 high risk
57 incidence
58 incidence rate
59 infection
60 levels
61 major decline
62 multivariate analysis
63 needle
64 patterns
65 period
66 person years
67 population level
68 prevalence
69 rate
70 recent years
71 reduced risk behavior
72 regression
73 risk
74 risk behaviors
75 risk factors
76 seroconversion
77 simultaneous decline
78 smooth trend
79 study
80 study entry
81 study period
82 time
83 trends
84 users
85 virus
86 years
87 schema:name Major decline of hepatitis C virus incidence rate over two decades in a cohort of drug users
88 schema:pagination 183-193
89 schema:productId N0195ebce34834f73ad981dbbc6cca3fa
90 N9a3d75a7346f4755b1221d2afd746e0d
91 Nec824beda2cb48a2abca1c0fa7a9901a
92 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034474780
93 https://doi.org/10.1007/s10654-006-9089-7
94 schema:sdDatePublished 2022-10-01T06:34
95 schema:sdLicense https://scigraph.springernature.com/explorer/license/
96 schema:sdPublisher Nf919d63f1973423499e181fbcb750f78
97 schema:url https://doi.org/10.1007/s10654-006-9089-7
98 sgo:license sg:explorer/license/
99 sgo:sdDataset articles
100 rdf:type schema:ScholarlyArticle
101 N0195ebce34834f73ad981dbbc6cca3fa schema:name doi
102 schema:value 10.1007/s10654-006-9089-7
103 rdf:type schema:PropertyValue
104 N01e3200ae30e43bb93b0ae5a67f30017 schema:volumeNumber 22
105 rdf:type schema:PublicationVolume
106 N06c6419b5eba4f88a5582b662cbba791 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Female
108 rdf:type schema:DefinedTerm
109 N15b1eaaa77e04a23b08a03e913e3a353 rdf:first sg:person.01322117344.51
110 rdf:rest Nf694e8ad6aa342b6896b754e9c819848
111 N243cd650765d4b3088e6c25b90138054 rdf:first sg:person.0741421421.32
112 rdf:rest Nd7bcd82552d64062a98b23fcd4634d1e
113 N3294ed72b96240928712d089b79a4982 rdf:first sg:person.01276615013.07
114 rdf:rest N243cd650765d4b3088e6c25b90138054
115 N4002edc04037450db4727e9fae7c77e1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Humans
117 rdf:type schema:DefinedTerm
118 N4c097eef145c425cb5e31bf255daf4fa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Hepatitis C
120 rdf:type schema:DefinedTerm
121 N4dba47bf563f4329948047d410618383 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Male
123 rdf:type schema:DefinedTerm
124 N59023a8af5554bb2a625e08855da6f19 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Risk Factors
126 rdf:type schema:DefinedTerm
127 N5c5914e873aa4a0bb3f1c83aa427be6f rdf:first sg:person.01257225511.14
128 rdf:rest N5d8fba1e730946d2931e9259468eae16
129 N5d8fba1e730946d2931e9259468eae16 rdf:first sg:person.0636370562.38
130 rdf:rest N15b1eaaa77e04a23b08a03e913e3a353
131 N5fdaf251c4554cacb6445f5d0153bc70 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Netherlands
133 rdf:type schema:DefinedTerm
134 N68083fd4f6104afcb79de01af1703294 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Substance Abuse, Intravenous
136 rdf:type schema:DefinedTerm
137 N695ec59fb6d144da9489039d3f2a4b24 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Needle Sharing
139 rdf:type schema:DefinedTerm
140 N9a3d75a7346f4755b1221d2afd746e0d schema:name pubmed_id
141 schema:value 17334821
142 rdf:type schema:PropertyValue
143 Na9df5627dbe6440cbc5b9c087b3fdb05 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Adult
145 rdf:type schema:DefinedTerm
146 Nabaa2005ff734ab785f75dd1b086ade7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name HIV Infections
148 rdf:type schema:DefinedTerm
149 Nafe79aa7288e4d90b932b81f3fa698b8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Serologic Tests
151 rdf:type schema:DefinedTerm
152 Nbf84998dc06a46d193bcbe2d407070b5 schema:issueNumber 3
153 rdf:type schema:PublicationIssue
154 Ncf1ab4e2b70144729ea4217e3c319aca schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Needle-Exchange Programs
156 rdf:type schema:DefinedTerm
157 Ncf7a296e1f504e3f81e86a547e9d55fe rdf:first sg:person.01233471631.26
158 rdf:rest N5c5914e873aa4a0bb3f1c83aa427be6f
159 Nd40c3f22b89544ada48fa39ca2e5f5c2 rdf:first sg:person.013427673122.44
160 rdf:rest N3294ed72b96240928712d089b79a4982
161 Nd7bcd82552d64062a98b23fcd4634d1e rdf:first sg:person.01205235647.85
162 rdf:rest Ncf7a296e1f504e3f81e86a547e9d55fe
163 Nec824beda2cb48a2abca1c0fa7a9901a schema:name dimensions_id
164 schema:value pub.1034474780
165 rdf:type schema:PropertyValue
166 Nf59fa8ada22d4bf6a1095634d08e6fc0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Incidence
168 rdf:type schema:DefinedTerm
169 Nf694e8ad6aa342b6896b754e9c819848 rdf:first sg:person.015770000052.12
170 rdf:rest rdf:nil
171 Nf919d63f1973423499e181fbcb750f78 schema:name Springer Nature - SN SciGraph project
172 rdf:type schema:Organization
173 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
174 schema:name Medical and Health Sciences
175 rdf:type schema:DefinedTerm
176 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
177 schema:name Clinical Sciences
178 rdf:type schema:DefinedTerm
179 anzsrc-for:1108 schema:inDefinedTermSet anzsrc-for:
180 schema:name Medical Microbiology
181 rdf:type schema:DefinedTerm
182 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
183 schema:name Public Health and Health Services
184 rdf:type schema:DefinedTerm
185 sg:journal.1095636 schema:issn 0393-2990
186 1573-7284
187 schema:name European Journal of Epidemiology
188 schema:publisher Springer Nature
189 rdf:type schema:Periodical
190 sg:person.01205235647.85 schema:affiliation grid-institutes:grid.5650.6
191 schema:familyName Geskus
192 schema:givenName Ronald B.
193 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01205235647.85
194 rdf:type schema:Person
195 sg:person.01233471631.26 schema:affiliation grid-institutes:grid.5650.6
196 schema:familyName Berkhout
197 schema:givenName Ben
198 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01233471631.26
199 rdf:type schema:Person
200 sg:person.01257225511.14 schema:affiliation grid-institutes:grid.5650.6
201 schema:familyName Jurriaans
202 schema:givenName Suzanne
203 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01257225511.14
204 rdf:type schema:Person
205 sg:person.01276615013.07 schema:affiliation grid-institutes:grid.5650.6
206 schema:familyName Smit
207 schema:givenName Colette
208 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01276615013.07
209 rdf:type schema:Person
210 sg:person.01322117344.51 schema:affiliation grid-institutes:grid.5650.6
211 schema:familyName Wolthers
212 schema:givenName Katja C.
213 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01322117344.51
214 rdf:type schema:Person
215 sg:person.013427673122.44 schema:affiliation grid-institutes:grid.5650.6
216 schema:familyName van den Berg
217 schema:givenName Charlotte H. S. B.
218 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013427673122.44
219 rdf:type schema:Person
220 sg:person.015770000052.12 schema:affiliation grid-institutes:grid.5650.6
221 schema:familyName Prins
222 schema:givenName Maria
223 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015770000052.12
224 rdf:type schema:Person
225 sg:person.0636370562.38 schema:affiliation grid-institutes:grid.5650.6
226 schema:familyName Coutinho
227 schema:givenName Roel A.
228 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0636370562.38
229 rdf:type schema:Person
230 sg:person.0741421421.32 schema:affiliation grid-institutes:grid.5650.6
231 schema:familyName Bakker
232 schema:givenName Margreet
233 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0741421421.32
234 rdf:type schema:Person
235 sg:pub.10.1007/bf00146260 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010552924
236 https://doi.org/10.1007/bf00146260
237 rdf:type schema:CreativeWork
238 sg:pub.10.1023/a:1014560431726 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020276587
239 https://doi.org/10.1023/a:1014560431726
240 rdf:type schema:CreativeWork
241 sg:pub.10.1093/jurban/jth084 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051686894
242 https://doi.org/10.1093/jurban/jth084
243 rdf:type schema:CreativeWork
244 grid-institutes:grid.5650.6 schema:alternateName Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, Amsterdam, The Netherlands
245 Department of Clinical Epidemiology and Biostatistics, Academic Medical Center, Amsterdam, The Netherlands
246 schema:name Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, Amsterdam, The Netherlands
247 Center for Infectious Disease Control, National Institute of Public Health and the Environment, Bilthoven, The Netherlands
248 Department of Clinical Epidemiology and Biostatistics, Academic Medical Center, Amsterdam, The Netherlands
249 Department of Human Retrovirology, Academic Medical Center, Amsterdam, The Netherlands
250 Department of Research, Cluster, Infectious Diseases, Health Service of Amsterdam, Nieuwe Achtergracht 100, 1018 WT, Amsterdam, The Netherlands
251 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...